beluuga.ai

Overview

Services

HONYAKU Center Inc.

Honyaku Center Inc. is a Japan-based translation and language services company offering specialized translation across patent, pharmaceutical, industrial/localization, and financial/legal domains, serving clients such as patent firms, pharmaceutical companies, manufacturers, and financial institutions. The company also provides interpretation services, translator/interpreter staffing (dispatch), software localization, DTP editing, and foreign patent application support. Its group companies cover complementary services including language education, multilingual call centers, and data collection/annotation.

Market Cap

US$42.6M

¥6.80B

US$12.1M

¥1.93B

StockUS$12.69(¥2,026)▲+0.90%

US$1 = ¥159.70 (2026-11-12)

LTM EV/EBITDA

3.3

LTM EV/EBIT

3.8

LTM PER

21.8

LTM PBR

1.0

Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-9.8%pt

Nov 13, 25 – Nov 13, 26StockTOPIX

1Aug 10, 26Q1 FY2027/03 earnings announced

MC → EV Bridge

AI Briefing

Honyaku Center: Japan's leading patent/pharma/industrial translation and language services provider, TSE Standard-listed with 5 subsidiaries. FY26/3 revenue US$68.3M (¥10.9B), OP margin compressed to 6.5% from 8.5% in FY23/3, signaling margin pressure despite stable topline. Shareholder base features M3 Inc. at 19.75% alongside multiple investment partnerships (UH Partners, Mitsubishi Corp-linked vehicles), pointing to a fragmented, financially-oriented ownership structure.

Open HONYAKU Center Inc. in the demo →Comps, DCF and WACC for this company. Free, no time limit.

Performance & Balance

Revenue 5Y (US$)

EBITDA 5Y (US$)

Net Income 5Y (US$)

Capital Structure

100%

EquityD/E 0.00xDebt

Liquidity vs Debt 5Y (US$)▲ Net Cash

CashInv. Sec.Debt

Business Segments

2026/03 · US$ (¥B)

Translation Business

Revenue

US$50.8M(¥8.11B)

Segment profit

US$3.41M(¥0.55B)6.7%

Interpretation Business

Revenue

US$8.29M(¥1.32B)

Segment profit

US$0.71M(¥0.11B)8.6%

Temporary Staffing Business

Revenue

US$7.04M(¥1.12B)

Segment profit

US$0.23M(¥0.04B)3.3%

Other

Revenue

US$2.06M(¥0.33B)

Segment profit

US$0.06M(¥0.01B)3.0%

Adjustments

Revenue

-US$0.12M(¥-0.02B)

Segment profit

US$0.00M(¥0.00B)

Shareholders

Top 10 hold 60.5%

as of 2026-09-30 · Source: Annual Securities Report

M3,Inc.

19.71%

UH Partners 3 Co., Ltd.

7.64%

UH Partners 2 Co., Ltd.

7.45%

SBI SECURITIES Co., Ltd.

6.71%

Hikari Tsushin Investment Limited Partnership, General Partner: Hikari Tsushin, Inc.

6.40%

SIL Investment Limited Partnership, General Partner: SIL, Inc.

5.53%

Shunichiro NINOMIYA

2.09%

Toshinori AKIMOTO

1.78%

HONYAKU Center Inc. Employee Stock Ownership Association

1.68%

MATSUI SECURITIES CO.,LTD.

1.48%

Management

7 officers

Shunichiro NINOMIYA

Representative Director, President

Apr 1997 Joined Honyaku Center Co., Ltd. Sep 2001 Manager, Tokyo Sales Department Jun 2004 Appointed Director (current) Apr 2007 Manager, Corporate Planning Office Sep 2012 Representative Director, President, I.S.S. Co., Ltd. Jun 2016 General Manager, Sales (concurrently in charge of Corporate Planning) Jun 2017 General Manager, Corporate Planning (concurrently Manager, Operations Promotion Department) Nov 2017 Representative Director, President, Media Research Institute Co., Ltd. (current) Jun 2018 Appointed Representative Director, President (current) Jul 2019 Representative Director, President, HC Language Solutions, Inc. Jan 2024 Representative Director, President, Fukuyama Sangyo Honyaku Center Co., Ltd. (current) Jun 2024 Representative Director, President, FIPAS Co., Ltd.

1969-07-21

Yoshinori TAKEYAMA

Director; General Manager, Sales (concurrently General Manager, Pharmaceutical Division; Manager, Pharmaceutical Division Production Department; Manager, Marketing Department)

Oct 2000 Joined the Company Apr 2008 Manager, Tokyo First Sales Department Sep 2009 Manager, Tokyo Second Sales Department Apr 2015 Manager, Pharmaceutical Sales Department Jun 2017 Appointed Director (current); General Manager, Sales (concurrently Manager, Pharmaceutical Sales Department) Nov 2017 General Manager, Sales (concurrently Manager, Pharmaceutical Sales Department and Manager, Industrial and Localization Sales Department) Apr 2019 General Manager, Sales (concurrently Manager, Industrial and Localization Sales Department) Jun 2020 Representative Director, President, Panasia Co., Ltd. (current) Apr 2021 General Manager, Sales Apr 2025 General Manager, Sales (concurrently General Manager, Pharmaceutical Division; Manager, Pharmaceutical Division Production Department; Manager, Marketing Department) (current)

1971-06-19

Masashi UOTANI

Director; General Manager, Administration (concurrently Manager, Accounting Department)

Apr 2002 Joined the Company Apr 2014 Manager, Accounting Department Jun 2018 Appointed Director; General Manager, Administration (concurrently Manager, Accounting Department) (current)

1973-09-25

Nana NISHINO

Director; General Manager, Operations

Dec 2002 Joined the Company Apr 2014 Manager, Quality Control Promotion Department Jun 2023 Appointed Director (current) Apr 2025 General Manager, Operations (current)

1973-09-08

Kotaro ONISHI

Director (Audit and Supervisory Committee Member)

Oct 1997 Joined Century Audit Corporation (now EY ShinNihon LLP) Jun 2001 Registered as Certified Public Accountant (current) Sep 2003 Representative, Kotaro Onishi CPA Office (current) Jan 2007 Representative Director, NEXT CENTURY Co., Ltd. Jun 2012 Corporate Auditor of the Company Sep 2017 Director, HAYAWAZA Co., Ltd. (current) Apr 2019 Chairman of the Board, NEXT CENTURY Co., Ltd. (current) Jun 2019 Appointed Director (Audit and Supervisory Committee Member) (current)

1968-08-27

Atsushi YAMAMOTO

Director (Audit and Supervisory Committee Member)

Apr 1999 Registered with Osaka Bar Association (current) Apr 2001 Joined Dojima Law Office Apr 2009 Transferred to Dojima Law Office LPC (current) Jun 2015 Outside Corporate Auditor, Revo International Co., Ltd. (current) Jun 2015 Appointed Director Jun 2019 Appointed Director (Audit and Supervisory Committee Member) (current) Jun 2021 Director (Audit and Supervisory Committee Member), Stella Chemifa Corporation (current)

1970-12-26

Junichi MURATA

Director (Audit and Supervisory Committee Member)

Apr 1981 Joined Matsushita Electric Industrial Co., Ltd. (now Panasonic Holdings Corporation) Oct 2007 Business Unit Manager, Development and Production Solutions Business Unit, Corporate Information Systems Company, Panasonic Holdings Corporation Aug 2010 Head of Information Planning Group, Head Office, Panasonic Holdings Corporation Apr 2011 Representative Director, President, Panasonic IT Solutions Co., Ltd. (Executive Officer, Panasonic Holdings Corporation) Jul 2011 Representative Director, Executive Vice President, Fujitsu IT Management Partners Co., Ltd. Jun 2021 Appointed Director (Audit and Supervisory Committee Member) (current)

1958-12-23

Large Shareholding Reports

UH Partners 3 Co., Ltd.

2025-09-26

7.64%→7.64%

Annual report (as of 2026-09-30): 7.64%

UH Partners 3 Co., Ltd.

2025-08-25

7.64%→7.64%

Annual report (as of 2026-09-30): 7.64%

Disclosures

No disclosures

Primary Source Filings

EDINET

2026-11-12

Semi-Annual Securities Report

Period: Apr 2026 – Mar 2027

HONYAKU Center Inc.

Try the full product

HONYAKU Center Inc.

Try the full product

More Japanese companies in Services